Danish drugmaker Novo Nordisk has reduced the price of its popular weight-loss drug, Wegovy, by up to 37% from its launch price in India. This move is aimed at increasing its market share in the fast-growing Indian market for obesity treatments. The company's document sent to distributors shows the price...
Eli Lilly’s Mounjaro Sees Strong Start in India
Eli Lilly's diabetes and weight-loss drug, Mounjaro, has received a "positive" response in India, with the company now focusing on meeting the significant demand in the world's most populous country. Lilly launched Mounjaro in India in March, ahead of competitor Novo Nordisk, tapping into a market grappling with increasing rates...